First line treatment of adult patients with primary immune thrombocytopenia: a real-world study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First line treatment of adult patients with primary immune thrombocytopenia: a real-world study
Authors
Keywords
-
Journal
PLATELETS
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2019-02-12
DOI
10.1080/09537104.2019.1572875
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chinese guidelines for treatment of adult primary immune thrombocytopenia
- (2018) Xin-guang Liu et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- High-dose dexamethasone or oral prednisone for immune thrombocytopenia?
- (2016) Bertrand Godeau Lancet Haematology
- High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis
- (2016) Siraj Mithoowani et al. Lancet Haematology
- High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial
- (2015) Y. Wei et al. BLOOD
- Can Immune Thrombocytopenia Be Cured with Medical Therapy?
- (2015) Eline Prak et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Bleeding complications in immune thrombocytopenia
- (2015) D. M. Arnold Hematology-American Society of Hematology Education Program
- Long-Term Effect of High-Dose Dexamethasone with or without Low-Dose Dexamethasone Maintenance in Untreated Immune Thrombocytopenia
- (2014) Banhe Din et al. ACTA HAEMATOLOGICA
- Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
- (2014) D. Gomez-Almaguer et al. BLOOD
- Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study
- (2014) J. Peng et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding
- (2013) David Grimaldi et al. ANNALS OF HEMATOLOGY
- Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
- (2013) S. Gudbrandsdottir et al. BLOOD
- Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group
- (2013) Kana Sakamoto et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia
- (2012) Mohammad Mashhadi et al. DARU-Journal of Pharmaceutical Sciences
- Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodies
- (2011) Qingshu Zeng et al. AMERICAN JOURNAL OF HEMATOLOGY
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
- (2011) C. Neunert et al. BLOOD
- International consensus report on the investigation and management of primary immune thrombocytopenia
- (2009) D. Provan et al. BLOOD
- Faster platelet recovery by high-dose dexamethasone compared with standard-dose prednisolone in adult immune thrombocytopenia: a prospective randomized trial
- (2009) W. PRAITUAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started